據報中信里昂證券香港債券銷售團隊流失逾半人手
彭博引述知情人士指,在北京母公司中信證券(06030.HK)加強對決策的控制下,中信里昂證券香港債券銷售固收團隊目前已流失超過一半人手。
消息指,中信里昂證券香港一個八人銷售團隊中,董事Tom Carlone、聯席董事Luke Yang及Gary Lam,以及經理Chris Wai及Cherry Chan共五名成員已先後於過去兩個月內離職。該知情人士指出,中信證券在過去一年加強對中信里昂證券香港的風險管控,包括收緊固定收益業務的可用資產負債表及控制薪資,導致多名高管紛紛離職。中信里昂證券發言人回應指不宜對此發表評論。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.